Evidence map›Paper›PMID 41703235›Full record

ArticleScientific reports2026

Low intensity vibration as a novel strategy to normalize age-related deficits in T cell proliferation, activation, and function.

Christopher P Ashdown, Ankur Sikder, Andreas G Kaimis, Meilin E Chan, Brian S Sheridan, Clinton T Rubin

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher P AshdownDepartment of Biomedical Engineering, College of Engineering and Applied Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794-5280, USA.
Ankur SikderDepartment of Biomedical Engineering, College of Engineering and Applied Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794-5280, USA.
Andreas G KaimisDepartment of Biomedical Engineering, College of Engineering and Applied Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794-5280, USA.
Meilin E ChanDepartment of Biomedical Engineering, College of Engineering and Applied Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794-5280, USA.
Brian S SheridanDepartment of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794-5280, USA.
Clinton T RubinDepartment of Biomedical Engineering, College of Engineering and Applied Sciences, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, 11794-5280, USA. Clinton.rubin@stonybrook.edu.

Funding

NIH HHS U-HL127522
6 · The paper itself

Abstract

Age related decline in number, activation, and function of T lymphocytes are hallmarks of immune dysfunction. Exercise is often described as the single best intervention to protect and promote robust immune function during aging. While these benefits are often presumed to be an indirect byproduct of increased metabolism, exercise may also deliver a direct benefit to the immune cell through its innate sensitivity to mechanical signals. We tested the hypothesis that mechanical stimulation, delivered non-invasively using low intensity vibration (LIV, at: 2 h of 30 Hz, 0.7 g) could augment T cell expansion without disrupting their phenotype, as well as improve the status of aged, dysfunctional, T cells. As compared to sham-handled controls, LIV increased proliferation 59% in T cells isolated from elderly patients (69.3y ± 2.6) while increasing expansion by only 13% in T cells harvested from young subjects (22.7y ± 3.8). T cell activation and production of pro-inflammatory cytokines (e.g., IL-2 by + 25%; p < 0.05) were also increased by LIV. Exploring whether this in vitro influence could translate to an in vivo model of aging, 4w of 30 min/d of LIV applied to 18-month-old mice resulted in significant increases in T cell activation as compared to sham-handled controls (102% increase in CD25 & 44.2% increase in CD69; p < 0.05). LIV also improved T cell anti-viral functionality, as 18-month-old mice pre-treated with 4w of LIV prior to infection with an Influenza A virus exhibited 18% less weight loss at 12d compared to sham-handled controls, a critical indication of a more robust immune system. These data suggest that extremely low magnitude mechanical signals, introduced non-invasively using LIV, represent a novel, non-drug therapeutic strategy for ameliorating age-related declines in immune function.

Indexed as

AgingLymphocyte ActivationT-LymphocytesVibrationAgedAnimalsCell ProliferationCytokinesFemaleHumansMaleMiceCytokines

Identifiers

PMID41703235
PMCPMC13002976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.